Synchronous Pulmonary Adenocarcinomas.

TitleSynchronous Pulmonary Adenocarcinomas.
Publication TypeJournal Article
Year of Publication2020
AuthorsPagan CA, Shu CA, Crapanzano JP, Lagos GG, Stoopler MB, Rizvi NA, Heymann JJ, Sonett JR, Fernandes H, Saqi A
JournalAm J Clin Pathol
Volume154
Issue1
Pagination57-69
Date Published2020 06 08
ISSN1943-7722
KeywordsAdenocarcinoma of Lung, Aged, Aged, 80 and over, Female, High-Throughput Nucleotide Sequencing, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Neoplasms, Multiple Primary
Abstract

OBJECTIVES: To determine concordance/discordance between morphology and molecular testing (MT) among synchronous pulmonary carcinomas using targeted next generation sequencing (NGS), with and without comprehensive molecular review (CMR), vs analyses of multiple singe genes (non-NGS).

METHODS: Results of morphologic and MT assessment were classified as concordant, discordant, or indeterminate. For discordant cases, comprehensive histologic assessment (CHA) was performed.

RESULTS: Forty-seven cases with 108 synchronous tumors were identified and underwent MT (NGS, nā€…=ā€…23 and non-NGS, nā€…=ā€…24). Histology and MT were concordant, discordant, and indeterminate in 53% (25/47), 21% (10/47), and 26% (12/47) of cases, respectively. CHA of the 10 discordant cases revised results of three cases.

CONCLUSIONS: There is discordance between histology and MT in a subset of cases and MT provides an objective surrogate for staging synchronous tumors. A limited gene panel is sufficient for objectively assessing a relationship if the driver mutations are distinct. Relatedness of mutations require CMR with a larger NGS panel (eg, 50 genes).

DOI10.1093/ajcp/aqaa023
Alternate JournalAm J Clin Pathol
PubMed ID32146481
Related Faculty: 
Jonas Heymann, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700